What, if Any, Role Is There for BRAF-Targeted Therapy in BRAF-Mutant Melanoma?

J Clin Oncol. 2022 Dec 20;40(36):4161-4165. doi: 10.1200/JCO.22.01066. Epub 2022 Jul 21.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Humans
  • Melanoma* / drug therapy
  • Melanoma* / genetics
  • Molecular Targeted Therapy
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / genetics

Substances

  • Proto-Oncogene Proteins B-raf
  • Protein Kinase Inhibitors
  • BRAF protein, human